AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$630M |
| 2 |
Visa
V
|
+$363M |
| 3 |
MSCI
MSCI
|
+$322M |
| 4 |
Walt Disney
DIS
|
+$297M |
| 5 |
Monster Beverage
MNST
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$584M |
| 2 |
Nike
NKE
|
+$573M |
| 3 |
Meta Platforms (Facebook)
META
|
+$489M |
| 4 |
Adobe
ADBE
|
+$418M |
| 5 |
Advanced Micro Devices
AMD
|
+$416M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.76% |
| 2 | Healthcare | 17.68% |
| 3 | Financials | 13.09% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
iShares Global Energy ETF
IXC
$2.79B
| $421K | ﹤0.01% |
12,640
-158,600
| -93% | -$5.56M |
|
2727
C4 Therapeutics
CCCC
$385M
| $418K | ﹤0.01% |
47,700
-3,100
| -6% | -$32.2K |
|
2728
Alkami Technology
ALKT
$1.94B
| $417K | ﹤0.01% |
27,700
+10,400
| +60% | +$151K |
|
|
SHOE
2729
Shoe Station Group
SHOE
$413M
| $416K | ﹤0.01% |
19,419
-1,378
| -7% | -$31.6K |
|
|
TWNI
2730
DELISTED
Tailwind International Acquisition Corp.
TWNI
| $416K | ﹤0.01% |
41,900
| – | – |
|
2731
Enviri
NVRI
$623M
| $415K | ﹤0.01% |
111,070
-1,515
| -1% | -$8.39K |
|
2732
Kodiak Sciences
KOD
$2.6B
| $414K | ﹤0.01% |
53,500
-1,000
| -2% | -$9.72K |
|
2733
Capital Southwest
CSWC
$1.47B
| $412K | ﹤0.01% |
+24,296
| New | +$468K |
|
|
PRVB
2734
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $412K | ﹤0.01% |
91,600
+4,700
| +5% | +$21.4K |
|
2735
Midland States Bancorp
MSBI
$698M
| $409K | ﹤0.01% |
17,357
+2,100
| +14% | +$54.2K |
|
|
JAMF
2736
DELISTED
Jamf
JAMF
| $408K | ﹤0.01% |
18,428
-327
| -2% | -$8.08K |
|
2737
Atara Biotherapeutics
ATRA
$75.5M
| $405K | ﹤0.01% |
4,282
+1,296
| +43% | +$146K |
|
2738
Sprinklr
CXM
$1.49B
| $405K | ﹤0.01% |
43,893
+27,763
| +172% | +$313K |
|
|
AGTI
2739
DELISTED
Agiliti Inc
AGTI
| $405K | ﹤0.01% |
28,307
-1,093
| -4% | -$20.3K |
|
|
ACLX
2740
DELISTED
Arcellx
ACLX
| $404K | ﹤0.01% |
+21,500
| New | +$411K |
|
|
FSRX
2741
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
| $403K | ﹤0.01% |
41,000
| – | – |
|
2742
FirstService
FSV
$6.48B
| $402K | ﹤0.01% |
3,375
+42
| +1% | +$5.37K |
|
|
TCBC
2743
DELISTED
TC Bancshares, Inc. Common Stock
TCBC
| $402K | ﹤0.01% |
27,964
| – | – |
|
2744
OraSure Technologies
OSUR
$279M
| $400K | ﹤0.01% |
105,519
+12,518
| +13% | +$45.2K |
|
|
TRST
2745
Trustco Bank Corp NY
TRST
$970M
| $399K | ﹤0.01% |
12,696
+1,615
| +15% | +$53.6K |
|
2746
Organogenesis Holdings
ORGO
$305M
| $398K | ﹤0.01% |
122,869
+11,569
| +10% | +$52.3K |
|
2747
Capital City Bank Group
CCBG
$888M
| $396K | ﹤0.01% |
12,744
+300
| +2% | +$9.54K |
|
|
AMRS
2748
DELISTED
Amyris Inc.
AMRS
| $396K | ﹤0.01% |
135,517
+6,917
| +5% | +$18.9K |
|
2749
TFS Financial
TFSL
$5.16B
| $395K | ﹤0.01% |
30,412
-1,968
| -6% | -$27.9K |
|
2750
Utah Medical Products
UTMD
$225M
| $392K | ﹤0.01% |
4,600
-100
| -2% | -$8.83K |
|
Similar funds
AllianceBernstein's Q3 2022 Portfolio in Review
As of Q3 2022, AllianceBernstein held 3,359 positions worth $207B, down 5.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
AllianceBernstein's Q3 2022 filing shows 102 new, 1,361 increased, 1,417 reduced and 89 closed positions. Its largest new stake was Genmab: 5,779,489 shares worth $186M. The largest sale was Qualcomm, an estimated $584M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q3 2022 buy was Genmab: 5,779,489 shares worth $186M.
- AllianceBernstein added most to iShares Russell 1000 Growth ETF in Q3 2022, an estimated $630M increase.
- AllianceBernstein's biggest Q3 2022 reduction was Qualcomm, cutting an estimated $584M.
- AllianceBernstein fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $244M.
- AllianceBernstein's ten largest holdings make up 23% of its $207B portfolio in Q3 2022.
- AllianceBernstein opened 102 new positions and closed 89 in Q3 2022.
- AllianceBernstein's portfolio value fell 5.7% quarter-over-quarter to $207B.
Based on AllianceBernstein's 13F filing for Q3 2022, filed 15 Nov 2022.